This content is machine translated Small papillary thyroid carcinomas Is active monitoring enough? There are some centers that advocate pursuing a strategy of active surveillance without surgery for small papillary thyroid carcinomas (PTC), which are increasingly encountered in clinical practice. A population-based cohort…
View Post 3 min This content is machine translated Rare Disease Day Step by Step December 2014 marked the 15th anniversary of European legislation on orphan drugs. Since that day, much has been achieved in Europe. In addition to EURORDIS – the European umbrella organization…
View Post 8 min This content is machine translated Therapies in geriatric oncology. Elderly patients with prostate or colorectal cancer As the population in Switzerland ages, even more people will develop cancer at an advanced age in the future. In these patients, treatment decisions are often complex because, due to…
View Post 7 min This content is machine translated Help via Internet Online interventions for cancer patients Internet-based interventions can help patients with certain diseases. The advantages of online interventions are their low-threshold nature, independence of time and place, and the absence of waiting times. In Switzerland,…
View Post 7 min This content is machine translated Immunological and molecular biological aspects MALT type gastric lymphoma MALT lymphomas most commonly affect the stomach. Causally, there is a strong association with Helicobacter pylori (Hp) gastritis (over 90% of patients). With adequate antibiosis, Hp can be eradicated, leading…
View Post 3 min This content is machine translated News from the ASH Congress on Nivolumab High response rates even in pretreated Hodgkin’s lymphomas Preclinical studies show that Sternberg-Reed cells, characteristic of classical Hodgkin lymphoma, use the PD-1 pathway to evade immunodetection. Therefore, immune checkpoint inhibitors such as nivolumab, which binds to the PD-1…
View Post 2 min This content is machine translated Immunosuppression in prostate cancer New therapeutic targets are being explored What is certain: The survival prognosis of metastatic castration-resistant prostate cancer (mCRPC) has improved – on average from just over one (before 2000) to almost three years [1]. Nevertheless, current…
View Post 2 min This content is machine translated Bladder Cancer Promising immunotherapy A new phase I trial with a compound targeting the immunosuppressive protein PDL1 shows promising results with a good toxicity profile. This provides a potentially new class of drugs for…
View Post 13 min Non-small cell lung cancer (NSCLC) Current concepts of radiation therapy Radiation therapy forms an integral component in the management of NSCLC. Recent advances in radiation therapy in NSCLC are based on both technical advances and the better understanding of the…
View Post 7 min This content is machine translated Surgical therapy for lung cancer Staging, operability, and prognostic factors determine the indication The choice of therapeutic modalities for lung cancer depends on several factors. Accurate staging, assessment of operability, and knowledge of prognostic factors such as the number of affected lymph node…
View Post 10 min This content is machine translated Oral cavity carcinoma Histopathological parameters are important prognostic factors Important risk factors for oral cavity carcinomas in our latitudes are tobacco and alcohol use, chronic infection with high-risk HPV, immunosuppression, and previous tumors in the head and neck region.…
